Qualified for Reg A+

Alzamend Neuro, Inc. was qualified by the SEC as of December 8th to generally solicit and crowdfund up to $50 million dollars of equity from the general public, accredited investors, and institutional investors, to support its strategic plans, through general solicitation and traditional mechanisms.

The post Qualified for Reg A+ appeared first on Alzamend.